Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | News | May 1, 2011

Mark A. Turco, MD, Joins Covidien as CMO of Vascular Products

May 2, 2011—Covidien (Mansfield, MA) announced that Mark A. Turco, MD, has joined the company as the Chief Medical Officer of its Vascular Products business. Dr. Turco will oversee the business's medical affairs operations in the United Sates and Europe, primarily focusing on clinical affairs, health economics and reimbursement, professional affairs, and clinical education.

evt | Article | October 2011 Supplement

Venous Solutions

By Mark A. Turco, MD, FACC

evt | Article | September 2006

Orbital Atherectomy

Initial experiences with a new system for the percutaneous treatment of peripheral vascular stenosis.

By Richard R. Heuser, MD; Robert Safian, MD; Marc Bosiers, MD; and Mark A. Turco, MD

evt | News | June 3, 2020

Sirtex Medical Appoints Dr. Mark Turco as Global Chief Medical Officer

June 3, 2020––Sirtex Medical US Holdings, Inc. announced the appointment of Mark A. Turco, MD, as Global Chief Medical Officer and Executive Vice President of Research & Development, effective June 1, 2020. Sirtex is focused on targeted radiation therapies for liver cancer, including SIR-Spheres yttrium-90 resin microspheres. The company has global headquarters in Woburn, Massachusetts.

Advertisement

Advertisement

evt | News | September 21, 2009

Boston Scientific Reports on ATLAS Small Vessel and Long Lesion Trial

September 22, 2009—Boston Scientific Corporation (Natick, MA) announced comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the company's Taxus Liberté paclitaxel-eluting stent system in a variety of lesions and patient groups.

evt | News | October 9, 2012

Final 12-Month Results From DEFINITIVE LE Study of Directional Atherectomy in PAD Patients Presented at VIVA

October 10, 2012—Covidien (Mansfield, MA) has announced the final 12-month results from the DEFINITIVE LE (Determination of Effectiveness of SilverHawk/TurboHawk Peripheral Plaque Excision Systems for the Treatment of Infrainguinal Vessels/Lower Extremities) study, which were presented at the Vascular InterVentional Advances (VIVA) meeting in Las Vegas.

evt | Article | June 2018

Creating CLI Teams

The VIVA Physicians' Vascular Leaders Forum offers guidance on core competencies and quality measures for establishing multidisciplinary CLI care teams.

By John H. Rundback, MD; Tony S. Das, MD; Peter A. Schneider, MD; and Michael R. Jaff, DO; on behalf of the VLF participants

evt | Article | June 2017

Ask the Experts: Where Do You See Percutaneous Arteriovenous Fistula Creation Fitting Into Practices in the Next Several Years?

Experts offer their outlook for the future of percutaneous arteriovenous fistula access creation.

With Sanford Altman, MD; Eric K. Peden, MD; Mark Turco, MD; and James F. McGuckin, Jr, MD

evt | Article | October 2006

Embolic Protection Devices in Aortocoronary Saphenous Vein Graft Intervention

Reduced MACE rates after intervention support continued use, although device development and innovation are imperative.

By Jason H. Rogers, MD, and Reginald I. Low, MD

evt | News | November 2, 2015

REALITY Study to Evaluate Directional Atherectomy Plus DCB Treatment for PAD

November 2, 2015—Medtronic plc announced the initiation of the REALITY study to evaluate patient outcomes following adjunctive use of directional atherectomy and drug-coated balloon (DCB) treatment of patients with symptomatic peripheral arterial disease (PAD) in long, calcified superficial femoral (SFA) and/or popliteal artery lesions.

evt | Article | June 2017

Dialogues in Dialysis Access

By Bart Dolmatch, MD, FSIR

evt | Article | June 2007

Excimer Laser as an Adjunct for Popliteal Aneurysms

A case report demonstrating the use of this novel technique.

By Mark W. Moritz, MD, FACS, and Michael Ombrellino, MD, FACS

evt | Article | October 2011

Atherectomy Today: Go Slow to Finish Fast

An update on the newest generation of atherectomy devices and how this technique is currently being used to treat peripheral vascular disease.

By Jihad A. Mustapha, MD, FACC, FSCAI

evt | Article | January 2016

Innovations

Sponsored by Cook Medical

evt | Article | March 2013 Supplement

Why Drug-Eluting Stents Are Cost Effective in the Superficial Femoral Artery

The importance of cost effectiveness in health care is accelerating. Implanting drug-eluting stents in the superficial femoral artery may offer a safe, effective, and economically valuable solution.

By Mark W. Burket, MD

evt | Article | February 2019

What We Know and What We Don't: Mechanical Thrombectomy for Large Core Strokes

A review of available study data with an emphasis on what data are still needed.

By Jay N. Dolia, MD; Raul G. Nogueira, MD; and Diogo C. Haussen, MD

evt | Article | August 2013

Ask the Experts:

What is your go-to option for treating in-stent restenosis?

With Antonio Micari, MD, PhD; Prof. Dr. med. Nicolas Diehm; Michael H. Wholey, MD, MBA; Jos C. van den Berg, MD, PhD; and Andrew J. Feiring, MD, FACC, FSCAI, FAHA

evt | Article | March 2008

The Promise of MR for TEVAR and EVAR

Obtaining both force and anatomic imaging and how this might affect endovascular repair.

By Felix J.V. Schlösser, MD; Hamid R. Mojibian, MD; Hence J.M. Verhagen, MD, PhD; Frans L. Moll, MD, PhD; David Gortler, PharmD; and Bart E. Muhs, MD, PhD

evt | Article | September 2006

Laser Treatment

Using the Spectranetics Turbo catheter to treat a calcified lesion and a thrombotic occlusion in the SFA

By Robert Gallino, MD

evt | Article | October 2020

Vascular Oncologic Emergencies

A review of arterial and venous complications of malignancy and oncologic care that necessitate urgent transcatheter intervention.

By Lin L. Zhu, MD, PhD; Anne M. Covey, MD; and Amy R. Deipolyi, MD, PhD


1
2

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button